Financial Performance - For the six months ended September 30, 2024, the group's revenue was approximately HKD 169.5 million, compared to HKD 116.6 million for the same period in 2023, representing an increase of 45.3%[25]. - The net profit for the six months ended September 30, 2024, was approximately HKD 16.4 million, a significant increase from HKD 1.5 million for the same period in 2023, marking a growth of 1,093.3%[25]. - The total comprehensive income for the period was HKD 16.4 million, compared to HKD 1.5 million for the same period in 2023, indicating a substantial improvement in overall financial performance[27]. - The basic earnings per share for the six months ended September 30, 2024, was HKD 2.05, compared to HKD 0.19 for the same period in 2023, reflecting a significant increase of 980.0%[27]. - The group reported a pre-tax profit of HKD 19.5 million for the six months ended September 30, 2024, compared to HKD 1.5 million for the same period in 2023, an increase of 1,200.0%[27]. - Total revenue for the six months ended September 30, 2024, was HKD 169,459,000, compared to HKD 116,640,000 in the same period last year, reflecting a growth of 45.2%[50]. - The profit for the same period was approximately HKD 16.4 million, compared to a profit of approximately HKD 1.5 million in the previous year[115]. Costs and Expenses - The cost of goods sold for the six months ended September 30, 2024, was HKD 22.2 million, up from HKD 15.1 million in the same period of 2023, reflecting an increase of 47.5%[27]. - Employee costs increased to HKD 61.1 million for the six months ended September 30, 2024, compared to HKD 44.9 million in the same period of 2023, an increase of 36.1%[27]. - Other expenses for the six months ended September 30, 2024, totaled approximately HKD 41.3 million, up from HKD 28.5 million in 2023, primarily due to increased promotional activities and consultation fees paid to doctors[132]. - The company incurred a tax expense of HKD 3,050,000 for the six months ended September 30, 2024, with no tax expense reported for the same period in 2023[60]. - Rental and related expenses for the six months ended September 30, 2024, were approximately HKD 4.2 million, compared to HKD 3.5 million in the same period of 2023[125]. Assets and Liabilities - Non-current assets as of September 30, 2024, amounted to HKD 153.8 million, an increase from HKD 111.8 million as of March 31, 2024, representing a growth of 37.5%[29]. - Current assets totaled HKD 81.3 million as of September 30, 2024, slightly down from HKD 82.7 million as of March 31, 2024, a decrease of 1.7%[29]. - Current liabilities increased to HKD 128,557,000 from HKD 111,530,000 as of March 31, 2024, primarily due to an increase in contract liabilities[37]. - The company's net assets rose to HKD 76,682,000 as of September 30, 2024, compared to HKD 60,252,000 at the end of the previous fiscal year[37]. - The total outstanding debt as of September 30, 2024, was HKD 65.2 million, an increase from HKD 45.5 million as of March 31, 2024, including lease liabilities of HKD 48.9 million[136]. - The company's total equity as of September 30, 2024, was approximately HKD 76.7 million, compared to HKD 60.3 million as of March 31, 2024[136]. Cash Flow - For the six months ended September 30, 2024, the company reported a net cash inflow from operating activities of HKD 45,283,000, a significant increase from HKD 6,967,000 in the same period last year[41]. - Cash and cash equivalents decreased by HKD 7,613,000 during the period, resulting in a balance of HKD 11,696,000 as of September 30, 2024[41]. - The company reported a net cash outflow from investing activities of HKD 59,123,000, indicating significant investment in growth initiatives[41]. Strategic Initiatives - The company opened several new centers in Tsim Sha Tsui, Central, and Causeway Bay to expand its operational scale, enhancing market penetration and profitability[114]. - The company launched several new brands during the year, including "Angus' Beauty Concept," "LASERKOOL," and "Face It," to diversify its service offerings[114]. - The company is investing in new technology development, allocating $10 million for R&D in the upcoming fiscal year[178]. - Market expansion plans include entering two new international markets by mid-2025, targeting a 25% increase in market share[179]. - The company is considering strategic acquisitions to enhance its product portfolio, with a budget of $100 million set aside for potential deals[178]. Governance and Compliance - The company has adopted the corporate governance code as per GEM Listing Rules Appendix 15 and has complied with all applicable provisions as of September 30, 2024[158]. - The company has established an audit committee consisting of three independent non-executive directors to review accounting policies and internal controls[159]. - The major shareholders, Mr. Ye and Ms. Fu, hold a combined 63.94% equity interest in the company through Equal Joy, owning 511,500,000 shares[168]. Future Outlook - The company provided an optimistic outlook for the next quarter, projecting a revenue growth of 10%[178]. - New product launches are expected to contribute an additional $50 million in revenue by the end of Q1 2025[179]. - The company aims to reduce operational costs by 5% through efficiency improvements in the next fiscal year[178]. - A new marketing strategy is being implemented, expected to increase brand awareness by 30% within the next six months[179].
亮晴控股(08603) - 2025 - 中期财报